95 related articles for article (PubMed ID: 5387264)
1. Modification of tumor regression by immunologic means.
Mihich E
Cancer Res; 1969 Dec; 29(12):2345-50. PubMed ID: 5387264
[No Abstract] [Full Text] [Related]
2. [Antitumor chemotherapy. Considerations on the potential role of immunity].
Mihich E
Pathol Biol; 1967 Feb; 15(3):209-14. PubMed ID: 4860732
[No Abstract] [Full Text] [Related]
3. Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine.
Danysz A; Wierzba K; Wutkiewicz M; Pniewska A; Pragłowski T; Burba-Anczewska I
Arch Immunol Ther Exp (Warsz); 1984; 32(3):345-9. PubMed ID: 6395826
[TBL] [Abstract][Full Text] [Related]
4. Further studies on the metabolic effects of 9-beta-D-arabinofuranosyl-9-H-purine-6-thiol.
Kimball AP; LePage GA; Allinson PS
Cancer Res; 1967 Jan; 27(1):106-16. PubMed ID: 6066998
[No Abstract] [Full Text] [Related]
5. Antitumor activity of N6-phenyladenosine, and inhibitor of adenosine utilization, in combination with related purine analogs.
Grindey GB; Divekar AY; Hakala MT
Cancer Res; 1973 Oct; 33(10):2459-63. PubMed ID: 4741936
[No Abstract] [Full Text] [Related]
6. The successful regression of large solid sarcoma 180 tumors by platinum compounds.
Rosenberg B; VanCamp L
Cancer Res; 1970 Jun; 30(6):1799-802. PubMed ID: 5457941
[No Abstract] [Full Text] [Related]
7. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.
Sartorelli AC; Booth BA
Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069
[No Abstract] [Full Text] [Related]
8. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
Kataoka T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):701-5. PubMed ID: 3963841
[TBL] [Abstract][Full Text] [Related]
9. Strain specificity of stimulated regression of sarcoma 180.
Bradner WT; Pindell MH
Cancer Res; 1965 Jul; 25(6):859-64. PubMed ID: 5834954
[No Abstract] [Full Text] [Related]
10. Effects of 2,2'(methylenediimino)bis-1,3,4-thiadiazole (NSC-143019) on tumor growth and immune responses in mice.
Matsumoto T; Ootsu K; Okada Y
Cancer Chemother Rep; 1974; 58(3):331-44. PubMed ID: 4152218
[No Abstract] [Full Text] [Related]
11. [Antineoplastic activity in mice of 4,4'-(2-methyl-1,4-piperazinodiyl)bis-(4-oxo)-propenyl-1-carboxylic-1 acid diethyl ester].
Graczyk J; Pakulska W; Groszkowski S; Najman L
Acta Pol Pharm; 1980; 37(2):249-54. PubMed ID: 7468274
[No Abstract] [Full Text] [Related]
12. Screening data from the Caner Chemotherapy National Service Center Screening Laboratories. XXIX.
Leiter J; Abbott BJ; Schepartz SA
Cancer Res; 1965 Dec; 25(11 Pt 2):1779-2061. PubMed ID: 5856668
[No Abstract] [Full Text] [Related]
13. Increased immunogenicity of drug-resistent L 1210 leukemias in CDF1 mice.
Nicolin A; Vadlamudi S; Goldin A
Arch Ital Patol Clin Tumori; 1970; 13(3):125-33. PubMed ID: 5521381
[No Abstract] [Full Text] [Related]
14. Prevention of therapeutically induced regression of sarcoma 180 by immunologic enhancement.
Ferrer JF; Mihich E
Cancer Res; 1968 Feb; 28(2):245-50. PubMed ID: 5641518
[No Abstract] [Full Text] [Related]
15. Spleen colony studies of leukemia L1210. 3. Differential sensitivities of normal hematopoietic and resistant L1210 colony-forming cells to 6-mercaptopurine (NSC-755).
Wodinsky I; Swiniarski J; Kensler CJ
Cancer Chemother Rep; 1968 Feb; 52(2):251-5. PubMed ID: 5646852
[No Abstract] [Full Text] [Related]
16. Antilymphocytic leukemic serum and chemotherapy in the treatment of murine leukemia.
Miller DG; Moldovanu G; Kaplan A; Tocci S
Cancer; 1968 Dec; 22(6):1192-8. PubMed ID: 5705781
[No Abstract] [Full Text] [Related]
17. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
Kataoka T; Akahori Y; Sakurai Y
Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor immunity in mice bearing sarcoma 180 after treatment with the combination of diazoacetylglycine hydrazide and 5-fluorouracil].
Baldini L; Brambilla G; Cavanna M; Parodi S
Boll Soc Ital Biol Sper; 1968 Mar; 44(5):443-6. PubMed ID: 5674632
[No Abstract] [Full Text] [Related]
19. Enhancement of the antitumor effect of 6-mercaptopurine by vitamin A.
Akiyama S; Masuda A; Tabuki T; Kuwano M; Komiyama S
Gan; 1981 Oct; 72(5):742-6. PubMed ID: 7199007
[TBL] [Abstract][Full Text] [Related]
20. Effect of splenectomy on the regression of transplantable tumors.
Ferrer JF; Mihich E
Cancer Res; 1968 Jun; 28(6):1116-20. PubMed ID: 5658442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
